COVID-19 is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States.

This was similarly seen in a smaller study by Villani et al., who reported a 50% decrease in new melanoma diagnoses post-lockdown, and although there was no difference in median Breslow thickness, there was a slight trend toward invasive disease compared with in situ (56% post-lockdown compared with 44% in 2019 and 55% in 2018). 19 A similar trend to more advanced disease also has been reported in nonsmall-cell lung cancer in Korea with higher presentation of stage III-IV disease in 2020 (74.7%) compared with previo

also in 4,078 other papers